Raras
Buscar doenças, sintomas, genes...
Síndrome Guillain-Barré
ORPHA:2103CID-10 · G61.0CID-11 · 8C01.0PCDT · SUSDOENÇA RARA

São um conjunto de doenças raras dos nervos que surgem após uma infecção, geralmente em pessoas que antes eram saudáveis. A Síndrome de Guillain-Barré (SGB) não tem uma forma única de se manifestar e inclui a polirradiculoneuropatia desmielinizante inflamatória aguda (AIDP), que é a forma mais comum e afeta a capa protetora dos nervos (mielina); a neuropatia axonal motora aguda (AMAN), que atinge as fibras nervosas que controlam os músculos; a neuropatia axonal sensitivo-motora aguda (AMSAN), que afeta tanto as fibras nervosas dos movimentos quanto as da sensibilidade; a Síndrome de Miller-Fisher (SMF); e algumas outras variantes regionais.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

São um conjunto de doenças raras dos nervos que surgem após uma infecção, geralmente em pessoas que antes eram saudáveis. A Síndrome de Guillain-Barré (SGB) não tem uma forma única de se manifestar e inclui a polirradiculoneuropatia desmielinizante inflamatória aguda (AIDP), que é a forma mais comum e afeta a capa protetora dos nervos (mielina); a neuropatia axonal motora aguda (AMAN), que atinge as fibras nervosas que controlam os músculos; a neuropatia axonal sensitivo-motora aguda (AMSAN), que afeta tanto as fibras nervosas dos movimentos quanto as da sensibilidade; a Síndrome de Miller-Fisher (SMF); e algumas outras variantes regionais.

Pesquisas ativas
13 ensaios
39 total registrados no ClinicalTrials.gov
Publicações científicas
12.887 artigos
Último publicado: 2026 Mar

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
3.5
Europe
Início
All ages
🏥
SUS: Cobertura parcialScore: 45%
PCDT disponívelCID-10: G61.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
5 sintomas
🫘
Rins
1 sintomas
💪
Músculos
1 sintomas
🫁
Pulmão
1 sintomas
😀
Face
1 sintomas

+ 14 sintomas em outras categorias

Características mais comuns

Polineuropatia desmielinizante aguda
Desmielinização periférica
Disfunção do esfíncter da bexiga urinária
Paraparesia
Ataxia da marcha
Febre recorrente
23sintomas
Sem dados (23)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 23 características clínicas mais associadas, ordenadas por frequência.

Polineuropatia desmielinizante agudaAcute demyelinating polyneuropathy
Desmielinização periféricaPeripheral demyelination
Disfunção do esfíncter da bexiga urináriaUrinary bladder sphincter dysfunction
ParaparesiaParaparesis
Ataxia da marchaGait ataxia

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico12.887PubMed
Últimos 10 anos200publicações
Pico2026129 papers
Linha do tempo
2026Hoje · 2026🧪 2005Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Multigenic/multifactorial.

PMP22Peroxisomal membrane protein 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Seems to be involved in pore-forming activity and may contribute to the unspecific permeability of the peroxisomal membrane

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (1)
EGR2 and SOX10-mediated initiation of Schwann cell myelination
EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
3229.9 TPM
Tecido adiposo
421.5 TPM
Cervix Ectocervix
415.8 TPM
Fallopian Tube
379.8 TPM
Cervix Endocervix
354.6 TPM
OUTRAS DOENÇAS (7)
Roussy-Levy syndromeCharcot-Marie-Tooth disease type 3hereditary neuropathy with liability to pressure palsiesCharcot-Marie-Tooth disease type 1E
HGNC:9118UniProt:Q9NR77

Variantes genéticas (ClinVar)

292 variantes patogênicas registradas no ClinVar.

🧬 PMP22: GRCh38/hg38 17p12(chr17:14174654-15579519)x1 ()
🧬 PMP22: GRCh38/hg38 17p12(chr17:14170219-15510549)x3 ()
🧬 PMP22: GRCh38/hg38 17p12(chr17:14184601-15581021)x1 ()
🧬 PMP22: GRCh38/hg38 17p12(chr17:14174654-15536883)x3 ()
🧬 PMP22: GRCh38/hg38 17p12(chr17:14191318-15520772)x3 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 11 variantes classificadas pelo ClinVar.

3
6
2
Patogênica (27.3%)
VUS (54.5%)
Benigna (18.2%)
VARIANTES MAIS SIGNIFICATIVAS
PMP22: NM_000304.4(PMP22):c.201del (p.Thr68fs) [Likely pathogenic]
PMP22: NM_000304.4(PMP22):c.434del (p.Leu145fs) [Pathogenic/Likely pathogenic]
PMP22: NM_000304.4(PMP22):c.353C>T (p.Thr118Met) [Conflicting classifications of pathogenicity]
PMP22: NM_000304.4(PMP22):c.260T>C (p.Leu87Pro) [Uncertain significance]
PMP22: NM_000304.4(PMP22):c.-134G>A [Uncertain significance]

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 34
2Fase 22
·Pré-clínico13
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Guillain-Barré

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

8 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

39 ensaios clínicos encontrados, 13 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
6.289 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 6.289

#1

Gelsolin-3: A Novel Myelin Autoantigen in Demyelinating Guillain-Barré Syndrome.

Annals of neurology2026 Mar 24

Although immunoglobulin G (IgG) autoantibodies against gangliosides are well-established in axonal Guillain-Barré syndrome (GBS), specific autoantibodies in demyelinating GBS-including acute inflammatory demyelinating polyneuropathy (AIDP) and its variant, bifacial weakness with paresthesias (BFP)-remain unidentified. We aimed to identify novel autoantibodies and clarify the immunological link between AIDP and BFP. Immunoprecipitation and mass spectrometry identified gelsolin from BFP serum IgG targeting non-compact, periaxonal myelin surrounding the nodes of Ranvier. Western blotting confirmed specific recognition of gelsolin-3, with no cross-reactivity to the other 2 isoforms. Anti-gelsolin-3 IgG prevalence was screened in 388 GBS patients and correlated with clinical and electrophysiological phenotypes. In vivo pathogenicity was assessed by intraneural IgG injection. Anti-gelsolin-3 IgG antibodies were detected in 24 GBS patients (6%, p < 0.001 vs both disease and healthy controls), with no positive controls. These autoantibodies were strongly associated with facial weakness (63% vs 18%, p < 0.001) and the AIDP electrophysiological classification (73% vs 31%, p < 0.001). In vivo, these IgG1 autoantibodies bound to the nodal regions, triggering complement-dependent nodal injury, voltage-gated sodium channel cluster disruption, and concomitant demyelination. These early pathogenic events preceded macrophage infiltration. Anti-gelsolin-3 IgG1 represents a novel biomarker linking AIDP and BFP. Our results provide the first evidence that AIDP can be formally classified as a nodo-paranodopathy. This IgG1-mediated, complement-dependent nodal injury establishes a unifying paradigm across GBS: nodal complement activation represents a shared mechanism underlying conduction block despite targeting distinct domains-the axolemma in AMAN and myelin components at the axon-myelin interface in AIDP. ANN NEUROL 2026.

#2

Exploring the link between adenovirus infection and Guillain-Barré syndrome in children: a case-based analysis.

The Turkish journal of pediatrics2026 Feb 27

Adenovirus infections are commonly associated with respiratory tract infections, conjunctivitis, gastrointestinal disturbances, and in some cases, more severe illnesses such as pneumonia. Guillain-Barré syndrome (GBS), a rare autoimmune disorder that causes progressive peripheral nerve inflammation and paralysis, has been linked to various infections, including viral ones. We describe two newly diagnosed pediatric cases of GBS following adenovirus infection. Both patients were previously healthy boys, aged 3 and 6 years. Adenovirus was detected by nasopharyngeal PCR shortly preceding the neurological manifestations. Both were treated with intravenous immunoglobulin (IVIG); one also required plasma exchange and respiratory support. Both recovered fully during follow-up. Additionally, a relevant case from the literature was reviewed for comparison. Treatment included respiratory support, IVIG and plasma exchange therapy. During the 12-month follow-up no severe complications were observed in our patients. In conclusion, while GBS is a well-established complication of several viral infections, including adenovirus, the association between adenovirus and GBS remains relatively underexplored. Our case reports, along with a review of the literature, highlight the rare but plausible link between adenovirus infection and the development of GBS. Although adenovirus infections are common, the occurrence of GBS following these infections appears to be uncommon, suggesting that additional factors may be at play. However, given the potential severity of GBS and the growing body of evidence, it is important for clinicians to remain vigilant for this rare complication in patients with a history of adenovirus infection.

#3

Postmarketing safety surveillance for GSK's AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study.

BMJ open2026 Mar 19

In May 2023, the US Food and Drug Administration (FDA) initially approved an AS01E-adjuvanted respiratory syncytial virus (RSV) prefusion F protein-based vaccine (adjuvanted RSVPreF3) for adults aged ≥60 years. The approval was expanded in June 2024 to include adults 50-59 years of age at increased risk for RSV-associated lower respiratory tract disease. In this paper, we describe the protocol of a postmarketing safety study evaluating the association between adjuvanted RSVPreF3 and new-onset Guillain-Barré syndrome (GBS), acute disseminated encephalomyelitis (ADEM) and atrial fibrillation (AF) among adults ≥50 years of age in the USA and provide our rationale for key methodological decisions. The potential associations between adjuvanted RSVPreF3 and GBS, ADEM and AF will be evaluated using secondary healthcare data and the self-controlled risk interval (SCRI) design. Data from five research partners in the USA spanning August 2023 through June 2030 will be used for the conduct of yearly monitoring queries and, sample size permitting, SCRI analyses. Claims-based definitions for new-onset outcomes (first diagnosis in 365 days) are: ≥1 inpatient diagnosis for GBS and ADEM; ≥1 inpatient or ≥2 ambulatory/emergency diagnoses for AF. The primary risk and control windows are 1-42 and 43-84 days, respectively, for GBS and ADEM; and 1-8 and 9-16 days for AF. SCRI analyses for GBS and ADEM will include chart-confirmed cases. SCRI analyses for AF will adjust for the positive predictive value obtained from validation against charts. Conditional Poisson regression will be used to calculate incidence rate ratios. This study was approved by the Institutional Review Boards (IRB) of Harvard Pilgrim Health Care Institute; WIRB-Copernicus Group, Inc and its affiliates (collectively, 'WCG'); WCG IRB, Inc; and Sterling IRB, with Federal Wide Assurance (FWA) numbers FWA00000100, FWA00033319 and FWA00025632, respectively, for all participating research partners. Study results will be shared with the US FDA and publicly disseminated through national or international clinical or scientific conferences and peer-reviewed publications. This protocol has been registered in the Heads of Medicines Agencies-European Medicines Agency Real World Data Catalogues (EUPAS1000000486).

#4

A case-control neuroimaging investigation of chronic Zika virus-infected adults.

Frontiers in human neuroscience2026

Systemic viral infections with neurotropic potential pose significant global health challenges. The Zika virus (ZIKV) is known for its pronounced neurotropism, with recent infectious clusters raising renewed public health concerns. While research has predominantly focused on congenital populations, growing evidence suggests that the mature central nervous system (CNS) is also vulnerable. However, no study has examined the long-term impact of ZIKV infection on the adult human brain. To address this gap, we studied a rare group of adult ZIKV patients presenting with both peripheral (Guillain-Barré Syndrome; GBS) and CNS-related neurological symptoms. We compared these patients at the chronic stage (5 to 12 months post-infection) to healthy controls and to patients with GBS of non-ZIKV etiology (total N = 43). Structural and functional measures included cortical thickness, white matter hyperintensities, diffusion metrics, and resting-state functional connectivity. Despite the rarity of both patient populations, power analyses indicated that our sample size could detect large group differences-effect sizes deemed reasonable given the severity of neurological symptoms in the ZIKV group. Nonetheless, our multimodal analyses yielded null results, with Bayesian statistics (where applicable) providing evidence for a lack of effects. The null findings suggest that chronic ZIKV infection in adults is not associated with brain changes of large magnitude. Importantly, this study offers detailed clinical characterization of a heavily understudied group. In light of recent ZIKV outbreaks, this characterization underscores the need to monitor, study, and provide longitudinal care to adult survivors of severe ZIKV infections.

#5

Deciphering the Breathless Future: A Novel Approach to Predicting Respiratory Failure in Children With Guillain-Barré Syndrome.

Pediatric neurology2026 Feb 18

The applicability and utility of clinical predictive models for respiratory failure in the pediatric Guillain-Barré syndrome (GBS) and Asian population are significantly constrained. Therefore, we aim to develop and validate a clinical prediction model to predict respiratory failure risk in pediatric GBS patients in China, alongside the economic immunological biomarkers in decision-making, and evaluate the Erasmus GBS Respiratory Insufficiency Score (EGRIS)-Kids score's efficacy. The retrospective study originated from our pediatric GBS cohort at Children's Hospital of Chongqing Medical University during 2014-2022. We utilized logistic regression to identify predictors and construct a nomogram and web-based dynamic nomogram. The net reclassification index and integrated discriminant improvement index were used to compare models after incorporating new indices, with bootstrapping validation. Our study included 175 children, among which 23 (13%) patients have developed respiratory insufficiency. Variables included in our score were: age (odds ratio [OR] 1.23), bulbar palsy (OR 23.17), bilateral hip flexion (OR 0.75), and platelet-to-lymphocyte ratio (PLR; OR 2.47). The area under the receiver operating characteristic curve of the nomogram was 0.899 (95% confidence interval 0.839-0.960). The calibration plots showed an adequate consistency between the reported and predicted occurrence. The EGRIS-Kids model yielded an area under the receiver operating characteristic curve of 0.849 (95% confidence interval 0.754-0.944) in our cohort and the incorporation of PLR exhibited an incremental value of 12.51% (P = 0.03). We performed the first external validation of the EGRIS-Kids score in Chinese children with GBS. Furthermore, we developed a new predictive model incorporating the PLR, which shows promise and additional value but requires further external validation.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC7.494 artigos no totalmostrando 196

2026

Gelsolin-3: A Novel Myelin Autoantigen in Demyelinating Guillain-Barré Syndrome.

Annals of neurology
2026

Exploring the link between adenovirus infection and Guillain-Barré syndrome in children: a case-based analysis.

The Turkish journal of pediatrics
2026

Guillain-Barré syndrome mimicking inflammatory myopathy with hyperCKemia and muscle MRI findings: a case report.

Acta neurologica Belgica
2026

Hypokalemic Periodic Paralysis: A Case Report of Acute Flaccid Quadriparesis Mimicking Guillain-Barré Syndrome.

Cureus
2026

Recent Advances in Guillain-Barré Syndrome: Neurological Disorder, Pathophysiology, Diagnosis, Treatment, and Challenges.

Current neuropharmacology
2026

Postmarketing safety surveillance for GSK's AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study.

BMJ open
2026

Rapid neurological recovery in Guillain-Barré syndrome treated with efgartigimod.

Scientific reports
2026

Guillain-Barré syndrome triggered by acute hepatitis E virus infection: The first reported case from Egypt.

The Journal of international medical research
2026

Guillain-Barré Syndrome in Pregnancy: A Systematic Review of Published Case Reports and Case Series with Obstetric and Neonatal Outcomes.

American journal of obstetrics &amp; gynecology MFM
2026

Case Report: Anti-GT1a antibody-associated ocular flutter.

Frontiers in immunology
2026

Safety monitoring of health outcomes following RSVPreF3 + AS01 and RSVPreF vaccination among Medicare beneficiaries aged 65 years and older in the United States, 2023-2024.

Vaccine
2026

Distinct cerebrospinal fluid profiles of astrocytic aquaporin-4 and GFAP in neuroinflammatory disorders.

Neurobiology of disease
2026

Motor Neuron Disease with Guillain-Barré Syndrome? Motor Band Sign with Anti-GQ1b Antibodies.

Diagnostics (Basel, Switzerland)
2026

West Nile Virus Lineage 2 Neuroinvasive Infection Presenting as Intraparenchimal Cerebral Hemorrage.

Healthcare (Basel, Switzerland)
2026

Screening of signaling pathways and hub genes in Guillain-Barré syndrome based on bioinformatics and machine learning.

BMC neurology
2026

Post-COVID-19 surge in Guillain-Barré syndrome during the Omicron wave in China with clinical characteristics and potential immune-mediated pathways.

Scientific reports
2026

General aspects of rehabilitation in Guillain-Barre syndrome: A literature review.

Medwave
2026

Infective Myositis with Guillain-Barré Syndrome in Enterococcus Infection.

The Journal of the Association of Physicians of India
2026

Validation of Guillain-Barré syndrome case identification in three heterogeneous VAC4EU real-world data sources in Spain using the Brighton Collaboration criteria.

Vaccine
2026

Bannwarth Syndrome in a Patient With Early-Stage Breast Cancer: An Atypical Manifestation of Lyme Neuroborreliosis.

Cureus
2026

Traumatic Cervical Myelopathy Masked by Alcohol Intoxication and Diagnostic Anchoring.

Cureus
2026

Overview of Immunotherapy Administration for Miller Fisher Syndrome in Japan: A Nationwide Retrospective Cohort Study.

Annals of clinical epidemiology
2026

A case-control neuroimaging investigation of chronic Zika virus-infected adults.

Frontiers in human neuroscience
2026

A narrative review of considerations when assessing potential relationships between Guillain-Barré syndrome and vaccines.

Human vaccines &amp; immunotherapeutics
2026

Deciphering the Breathless Future: A Novel Approach to Predicting Respiratory Failure in Children With Guillain-Barré Syndrome.

Pediatric neurology
2026

Clinical and economic outcomes of therapeutic plasma exchange and intravenous immunoglobulin for treating adults with autoimmune neurological disorders: a systematic review and meta-analysis.

BMC neurology
2026

Atypical Guillain-Barre Syndrome with Positive Pyramidal Tract Signs and Anti-GM2 IgM Antibody.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
2026

Guillain-Barré syndrome clinical characteristics and outcomes among U.S. active component service members, 2014-2022.

MSMR
2026

Polymyxin-Associated Neurotoxicity: A Case of Guillain-Barré Syndrome Temporally Linked to Colistin Methanesulfonate and Respiratory Paralysis with Polymyxin B.

Infection and drug resistance
2026

Safety and Efficacy of Low-Volume Plasma Exchange in the Management of COVID-19-Associated Guillain-Barré Syndrome: A Case Report.

Journal of clinical apheresis
2026

Frequency of Anti-Ganglioside Antibodies and Their Clinical Correlates in Guillain-Barré Syndrome: A Single-Centre Study in Pakistan.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
2026

[Comment on the article: "Epidemiological and clinical aspects of Guillain-Barré syndrome, 2012-2022"].

Revista medica del Instituto Mexicano del Seguro Social
2026

An Atypical Presentation of Guillain-Barré Syndrome: Bilateral Facial Nerve Palsy With Preserved Reflexes.

Cureus
2025

[A case of Guillain-Barré syndrome due to infection with Rickettsia conorii in Tunisia].

Medecine tropicale et sante internationale
2026

Real-world evidence on RSV vaccine uptake, effectiveness, and safety in older adults: a systematic review and meta-analysis.

The Lancet regional health. Europe
2026

The Differential Diagnosis of Coma in the ICU: Hyperacute Postoperative Guillain-Barré Syndrome-A Case Report.

Clinical case reports
2026

IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal RSV infections in immunocompromised patients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2026

Differences in Neuropathic Pain as a Distinguishing Symptom in Dry Beriberi Mimicking Guillain-Barre Syndrome.

Journal of clinical neuromuscular disease
2026

Medulloblastoma masquerading as tuberculous meningitis in a pediatric patient.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2026

IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal Influenza infections in immunocompromised patients.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2026

A rare presentation of CASPR2-associated Morvan syndrome overlapping with GM1-positive AMSAN: a case report.

Frontiers in immunology
2026

Human Herpesvirus 6-Associated Miller-Fisher Syndrome in a 5-Year-Old Child: A Case-Based Narrative Review of Pediatric Cases with Infectious Triggers.

Viruses
2026

Bilateral Facial Palsy and Epstein-Barr Infection in Children: A Case Report and Literature Review.

Viruses
2026

The eye as a diagnostic key: the ophthalmologist's role in an atypical case of Miller Fisher Syndrome.

Archivos de la Sociedad Espanola de Oftalmologia
2026

Measurement properties of the Inflammatory Rasch-built Overall Disability Scale (I-RODS) in patients with Guillain-Barré syndrome.

Journal of neurology
2026

Analysis of the incidence status and risk factors for immune-mediated neuropathies: a single-center case-control study.

Frontiers in neurology
2026

Overlap of severe hypokalaemia and Guillain-Barré syndrome following Salmonella infection: a rare double etiology of acute lower limb paralysis - case report.

BMC infectious diseases
2026

Trajectory of Recovery and Burden of Residual Symptoms Following Guillain-Barré Syndrome: A Single-Center Prospective Cohort Study From Sri Lanka.

Journal of the peripheral nervous system : JPNS
2026

Climatic and Geographic Variations of Antecedent Infections in Guillain-Barré Syndrome: A Long-Term Longitudinal Analysis From Bangladesh.

Journal of the peripheral nervous system : JPNS
2026

Timeliness and Diagnostic Yield of Suspected Botulism Notifications in a Tertiary Medical Center in Taiwan, 2014-2024.

Journal of food protection
2026

Active surveillance methods to identify adverse events of special interest (AESIs) following vaccination against pandemic diseases: A scoping review.

Vaccine
2026

Rehabilitation challenges and progress in a patient with sensory ataxic Guillain-Barré syndrome: a case report.

Physiotherapy theory and practice
2026

A case report of arsenic-induced peripheral neuropathy misdiagnosed as Guillain-Barré syndrome.

Frontiers in toxicology
2026

Ictero-hemorrhagic leptospirosis -Weil's disease.

IDCases
2025

The journey to diagnosis for patients with CIDP: results from a real-world international survey.

Frontiers in neurology
2026

Zika virus and host protein interactions for understanding molecular mechanisms of pathogenesis and therapeutic development.

Frontiers in cellular and infection microbiology
2026

Peripheral blood T-cell subsets combined with EGRIS score predict the need for mechanical ventilation in Guillain-Barré syndrome.

Frontiers in immunology
2026

A case report of neurosarcoidosis mimicking Guillain-Barré syndrome: the diagnostic utility of skin biopsy in neurosarcoidosis.

BMC neurology
2026

A Case Report of Guillain-Barré Syndrome Presenting as Facial Diplegia: A Deviation From the Classical Ascending Paralysis.

Cureus
2026

Clinical response to therapeutic plasma exchange in patients with immune-mediated inflammatory diseases of the central nervous system.

Anales de pediatria
2025

First Paediatric Case of mRNA COVID-19 Vaccine Associated New Onset Systemic Myasthenic Crisis.

Sisli Etfal Hastanesi tip bulteni
2026

Efgartigimod for Guillain-Barré syndrome: a retrospective analysis of efficacy and safety.

Therapeutic advances in neurological disorders
2026

Case Report: Absent F-Waves in a Case of Spinal Ischemia - A Potential Source of Diagnostic Error.

Case reports in neurology
2026

Exploring the Role of Nuclear Factor Kappa B in the Immunobiology of Inflammatory Neuropathies.

Annals of Indian Academy of Neurology
2026

Before GBS can be attributed to an infection with Campylobacter jejuni, this pathogen must be confirmed.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2026

Temporary Pacemaker in a Pediatric Guillain-Barré Case With Life-Threatening Bradyarrhythmia: Clinical Letter.

Pediatric neurology
2026

Guillain-Barré Syndrome: Changing Landscape and Environmental Influences.

Indian pediatrics
2026

Current and Emerging Strategies for the Prevention of Respiratory Syncytial Virus (RSV) Infections: A Comprehensive Review of Vaccines and Antibody Therapies.

Cureus
2026

Can patient-reported outcome measures predict mortality in neurological populations? A systematic review.

Frontiers in neurology
2026

C-Reactive Protein and Neurological Autoimmune Diseases: Bridging the Diagnostic and Pathogenic Gap.

International journal of molecular sciences
2026

Fusion of molecular mimicry, epigenetic predisposition, and new onset GBS: a narrative review of current understanding and future directions.

Annals of medicine and surgery (2012)
2026

Diphtheria Presenting With Cranial Neuropathy: The Patch Unseen.

Cureus
2026

Guillain-Barré Syndrome Following Rabies Vaccination: An Unusual Descending Presentation.

Annals of Indian Academy of Neurology
2026

Recurrent Miller Fisher Syndrome: A Case Report.

Clinical practice and cases in emergency medicine
2026

Case Report: Complete remission of Guillain-Barré syndrome in neuropsychiatric lupus with telitacicept.

Frontiers in immunology
2026

Seasonal dynamics, antimicrobial resistance, and genetic lineages of thermotolerant Campylobacter isolates from South American camelids.

Science in One Health
2026

Prevalence and Patterns of Cranial Nerve Involvement in CIDP, Autoimmune Nodopathy, MMN, and Anti-MAG Neuropathy: A Multicenter Korea/UK Study of 582 Patients.

European journal of neurology
2026

Dynamics of Nerve Conduction Studies in Patients With Guillain-Barré Syndrome.

Muscle &amp; nerve
2026

Clinical and Electrophysiological Spectrum of Guillain-Barré Syndrome in Syria: A Prospective Cohort Study Highlighting Atypical Presentations.

Neuroepidemiology
2026

COVID-19 and Neonatal Guillain-Barré Syndrome: Exploring a Possible Causal Link With Review of Literature.

Journal of child neurology
2026

Acute Polyradiculoneuropathy in a Patient With Squamous Cell Carcinoma of the Cervix: A Diagnostic Challenge.

Cureus
2026

A Lyme Neuroborreliosis Case Presenting With Ophthalmoplegia, Dysarthria, and Spastic Quadriparesis.

Cureus
2026

Pyridostigmine Treatment for Pediatric Axonal Guillain-Barré Syndrome.

Muscle &amp; nerve
2026

Two Frontlines, One Diagnosis: Family Medicine-Neurology Collaboration Enables Early Recognition and Treatment of Acute Inflammatory Demyelinating Polyneuropathy in a Diabetic Patient.

Cureus
2026

Anti-GM1 antibodies in Bickerstaff's brainstem encephalitis.

BMJ case reports
2026

Neuromuscular Scoliosis as a Rare Manifestation of Guillain-Barré Syndrome in a Child.

Cureus
2026

Predictive value of neuroelectrophysiological parameters for respiratory failure in Guillain-Barré syndrome patients.

Neurological research
2026

Unveiling a Regional Variant of Demyelinating Guillain-Barré Syndrome: Nerve Conduction Study Evidence in Bifacial Weakness With Paresthesias.

Journal of the peripheral nervous system : JPNS
2026

MRI as a key tool in presumptive antemortem diagnosis of rabies: A case report.

Radiology case reports
2026

Augmented reality assisted physiotherapy rehabilitation in early phase of guillain barre syndrome (AIDP)-a case report.

BMC neurology
2026

First report of laboratory-confirmed Zika virus infection in human from South Karnataka, India: A case study.

Journal of virological methods
2025

West Nile Virus as a Trigger for Acute Inflammatory Demyelinating Polyneuropathy: Exploring Intravenous Immunoglobulin (IVIG) Efficacy and Disease Variability.

Cureus
2026

Challenges in managing prolonged intensive care unit stay for Guillain-Barré syndrome-acute motor axonal neuropathy variant.

SAGE open medical case reports
2026

Silent electrolyte imbalance unmasked by paralysis: a case of hypokalemia in a middle-aged woman.

Clinical biochemistry
2025

Not All Ascending Weakness and Numbness Is Guillain-Barré Syndrome: A Report of Two Cases of Copper Deficiency Myelopathy.

Cureus
2025

Diagnostic biomarkers for differentiating AQP4-IgG- negative NMOSD from other nervous system autoimmune disorders: a retrospective study.

Frontiers in immunology
2026

Clinical profile and predictors of guillain-barre syndrome associated pneumonia: a retrospective cohort study.

BMC neurology
2026

Takotsubo Cardiomyopathy due to Guillain-Barré Syndrome and Thyroid Storm: A Case Report.

Acta neurologica Taiwanica
2026

Anti-GQ1b Antibody Syndrome: A Clinician-Oriented Perspective on Diagnostics, Therapy, and Atypical Phenotypes-With an Illustrative 16-Case Institutional Series.

Journal of clinical medicine
2025

Feasibility of Smartphone-Based Markerless Motion Capture for Quantitative Gait Assessment in Pediatric Guillain-Barré Syndrome: A Two-Case Proof-of-Concept Study.

Bioengineering (Basel, Switzerland)
2025

Plasma exchange following immunoglobulins for Guillain-Barré-Syndrome: a persisting problematic practice?

Frontiers in neurology
2026

Utilizing internal analytics and physician-director collaborations to enhance neurological health communication on YouTube.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2026

Dysautonomia after COVID-19 infection: A case report.

Neurologia
2026

Incidence of Guillain-Barré Syndrome in Chile: A Population-Based Study Between 2013 and 2022.

Journal of the peripheral nervous system : JPNS
2026

MR neurography of tibial and common peroneal nerves in patients with Guillain-Barre syndrome and electrophysiological correlation.

BMC neurology
2025

[Acute inflammatory polyradiculoneuritis (Guillain-Barré syndrome)].

La Revue du praticien
2025

Case Report: Guillain-Barré syndrome temporally associated with levofloxacin exposure and improvement following efgartigimod treatment.

Frontiers in immunology
2026

Patient Perspective: Words That Matter: Reflections on a Patient's Experiences With Guillain-Barré Syndrome.

Neurology
2026

Patterns of Seasonality and Subtype-Linked Outcomes of Pediatric Guillain-Barré Syndrome ICU Admissions: A 10-Year Audit from Southern India.

Indian pediatrics
2025

Case Report: A rare pediatric case of hepatitis B virus infection with acute disseminated encephalomyelitis/Guillain-Barré syndrome spectrum diseases.

Frontiers in pediatrics
2026

Acute Urinary Retention and Guillain-Barré Syndrome: A Zebra or a Horse.

Journal of the American College of Emergency Physicians open
2026

Neurological Complications Associated With COVID-19 Compared to Other Viral Infections: A Systematic Review of Current Evidence.

Cureus
2025

A rare case of diffuse large B-cell lymphoma masquerading as Guillain Barre syndrome, Warburg phenomenon and hemophagocytic lymphohistiocytosis.

Ecancermedicalscience
2025

Development and evaluation of loop-mediated isothermal amplification (lamp) for rapid detection of campylobacter jejuni.

Revista peruana de medicina experimental y salud publica
2026

Longitudinal Monitoring of Systemic Cytokines After Mild Zika Virus Infection Revealed an Association Between Th17 Polarization and Clinical and Serological Outcomes.

Journal of medical virology
2026

Safety of immune checkpoint inhibitors: A systematic review of disproportionality analysis studies.

European journal of clinical pharmacology
2026

Hyperacute Guillain-Barré Syndrome: A Pathophysiological Interpretation.

Internal medicine (Tokyo, Japan)
2026

Guillain-Barré syndrome with unilateral oculomotor nerve palsy and anti-GM3 IgG antibodies.

Science progress
2026

Immunotherapies on Guillain-Barré syndrome and other acute autoimmune neuropathies.

Handbook of clinical neurology
2026

Intravenous immunoglobulin use in neurology.

Handbook of clinical neurology
2025

Isolated Vertigo as an Early Sign of Anti-GQ1b-Positive Miller Fisher Syndrome: Expanding the Spectrum.

Cureus
2025

Thyrotoxic Periodic Paralysis (TPP): A Comprehensive Review with Regional Insights from the Middle East.

Cureus
2025

Navigating Diagnostic Dilemmas: Miller Fisher Syndrome in Pregnancy Masquerading As Stroke.

Cureus
2026

DISTRICTS trial: enhancing carpal tunnel syndrome treatment - Authors' reply.

Lancet (London, England)
2026

Paraneoplastic neurological syndrome with Guillain-Barré syndrome overlap in small-cell lung carcinoma: A case report from a primary care hospital in China.

Medicine
2025

Early Sensory-Predominant Guillain-Barré Syndrome With Normal Cerebrospinal Fluid and MRI Findings: A Diagnostic Challenge.

Cureus
2026

Osmotic Nephropathy Induced by L-Proline Stabilized Sucrose-free Intravenous Immunoglobulins: A Case Report.

Kidney medicine
2025

Artificial Intelligence in Neurology: Assessing the Diagnostic and Therapeutic Reasoning of Large Language Models.

Cureus
2026

Malnutrition, contaminated water, and post-infectious neuropathies: lessons from the Guillain-Barré syndrome outbreak in Gaza.

Annals of medicine and surgery (2012)
2026

Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysis.

Journal of the neurological sciences
2026

Utility of the "Modified Erasmus GBS Respiratory Insufficiency Score" in Axonal and Demyelinating Guillain-Barré Syndrome.

Journal of the peripheral nervous system : JPNS
2026

A case report: Guillain-Barré syndrome probably associated with TNF inhibitor in Blau syndrome.

BMC pediatrics
2026

Serum Galectin-3 as a biomarker in acute inflammatory polyradiculoneuropathies: a cohort study.

Journal of neurology
2025

Systematic Review and Meta-Analysis of the Incidence of Myocarditis and Guillain-Barré Syndrome in Adolescents Receiving COVID-19 mRNA Vaccine.

Cureus
2025

Double Trouble: Guillain-Barré Syndrome (GBS) Presenting as Overlapping Miller Fisher Syndrome (MFS) and Pharyngeal-Cervical-Brachial (PCB) Variant.

Cureus
2026

Miller Fisher Variant of Guillain-Barré Syndrome Presenting With Dysphagia and Ophthalmoplegia.

Cureus
2025

CAPOS and Beyond: ATP1A3 Variants in Pediatric Movement Disorders - Case Reports.

Molecular syndromology
2025

Decoding Alexander the Great's gastrointestinal cause of death using artificial wisdom: An artificial intelligence-human inquiry into a medical mystery.

World journal of gastroenterology
2025

Eosinophilic Granulomatosis With Polyangiitis Presenting as a Mononeuritis Multiplex Mimicking Guillain-Barré Syndrome.

Cureus
2026

Phenotypic continuum in IGHMBP2-related disorders: a portfolio of cases from typical to Guillain-Barré syndrome-like presentation.

Neuromuscular disorders : NMD
2026

Patient Outcomes Among Medicare Beneficiaries With Guillain-Barré Syndrome.

Journal of the peripheral nervous system : JPNS
2025

A Review of Cutaneous Viral Infections and Their Potential Role in Neurologic Diseases.

Journal of clinical medicine
2025

Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Clinical Features, Diagnostic Challenges, and the Role of Oxidative Stress in Pathophysiology.

Antioxidants (Basel, Switzerland)
2025

Rapidly Progressive Guillain-Barré Syndrome (GBS) as a Critical Predictor of Early Mechanical Ventilation and Prolonged Hospitalization: An Observational Study at a Tertiary Care Hospital.

Cureus
2025

Atypical Acute Motor Axonal Neuropathy (AMAN) Presenting Concurrently With Community-Acquired Pneumonia and Respiratory Failure: A Case Report.

Cureus
2026

Post-infectious Guillain-Barré syndrome during a cholera outbreak in Yemen: A pediatric case with confirmed Campylobacter exposure.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2025

Commentary: Malnutrition and nutritional deficits as aggravating factors in Guillain-Barré syndrome: a call for nutritional intervention in the Gaza Strip.

Frontiers in public health
2025

Systemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy in Pregnancy: A Rare Multisystem Presentation.

Cureus
2025

Antibody glycosylation in neuroimmune diseases.

Journal of translational medicine
2026

Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial.

The Lancet. Oncology
2026

Reliability of online health information: evaluation of Guillain-Barré Syndrome videos on YouTube.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2025

Guillain-Barré Syndrome in the Third Trimester of Pregnancy: A Case Report and Literature Review.

The American journal of case reports
2026

Acute Autonomic Sensory Neuropathy Causing Severe Hyponatremia: A Rare Cause of Syndrome of Inappropriate Antidiuresis.

JCEM case reports
2026

Is there a causal nexus between norovirus infection and Guillain-Barré syndrome: The lessons learnt from GBS outbreak in Pune, India, 2025.

Journal of the neurological sciences
2025

Urodynamic evaluation of neurogenic lower urinary tract dysfunction in children with Guillain-Barre syndrome within 6 months.

Frontiers in neurology
2025

The outcome of severe Guillain-Barré syndrome after robotic or conventional rehabilitation also depends on the triggering agent and the electrophysiological subtype.

European journal of translational myology
2025

Foodborne Botulism Presenting With Isolated Cranial Nerve Involvement in a Young Adult.

Cureus
2025

Highly Immunoresistant Acute Motor and Sensory Axonal Neuropathy With Concomitant Anti-NF155 Axonal Nodopathy: A Case Report.

Cureus
2025

Norovirus infection associated with unusual fatal case of Guillain-Barré syndrome in the community outbreak in Pune, India.

Virology journal
2025

Dengue virus infection and Guillain-Barré syndrome: a systematic review of clinical characteristics, outcomes, and predictors of severity.

BMC infectious diseases
2026

Fine Motor Outcomes in Children with Guillain-Barré Syndrome.

Indian journal of pediatrics
2025

Clinical analysis of the development of Guillain-Barré syndrome during bortezomib treatment for multiple myeloma.

Frontiers in neurology
2025

Comparative Analytical Performance of Autoimmune Nodopathy Diagnostic Assays.

Annals of laboratory medicine
2025

The TH1/TH2 Response Imbalance Zika Virus Pathogenesis: An Immunological Paradox.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
2025

The Neuroprotective Effect of 4-Octyl Itaconate on Acute Period of Experimental Autoimmune Neuritis.

Inflammation
2025

Post-COVID Myoclonus-Ataxia Syndrome: A Case Report of Successful Recovery With Intravenous Immunoglobulin (IVIG) Treatment.

Cureus
2025

Ultrasonographic Evaluation of Peripheral Nerves for Early Diagnosis of Guillain-Barré Syndrome: A Case-Control Study.

Health science reports
2025

Zika virus exacerbates EAE by inducing the production of T cell-attracting chemokines in astrocytes.

International immunology
2025

Guillain-Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance study.

Journal of neurology
2025

MCC950 Alleviates Experimental Autoimmune Neuritis by Inhibiting NLRP3 Inflammasome Activity and Down-Regulating Interleukin-23/Interleukin-17 Axis Expression.

Journal of inflammation research
2025

Intermittent immunoadsorption in critically ill patients with neuroimmunological disorders: a retrospective study.

Frontiers in neurology
2026

Axonal Versus Demyelinating Guillain-Barré Syndrome Subtypes in Critically Ill Children: Clinical and Autonomic Profiles.

Pediatric neurology
2025

Preceding infection and anti-GQ1b antibody in Miller Fisher syndrome.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Guillain-Barré Syndrome with Discharges Following Compound Muscle Action Potentials: A-waves, M Dispersion or After-Discharges?

Noro psikiyatri arsivi
2025

Assessing the risk of Guillain-Barré syndrome in older adults after bivalent RSV pre-F vaccination in England.

Nature communications
2025

Acute Viral-Induced Myopathy Following Covid-19.

European journal of case reports in internal medicine
2025

Guillain-Barré syndrome and albuminocytological dissociation: a narrative review.

Annals of medicine and surgery (2012)
2025

Guillain-Barré Syndrome in war-torn regions: the forgotten neurological emergency in humanitarian crises.

Annals of medicine and surgery (2012)
2025

Antibody Positive Miller-Fisher Syndrome and Acute Motor Sensory Axonal Neuropathy With Respiratory Failure: A Rare Overlap.

Cureus
2025

Novel Application of Transcutaneous Electrical Stimulation for Ophthalmoplegia in Miller Fisher Syndrome: A Case Report.

Healthcare (Basel, Switzerland)
2025

Spectrum of Neuromuscular Manifestations in Dengue: A Systematic Review of Case Reports and Case Series.

Annals of Indian Academy of Neurology
2025

Recurrent Guillain-Barré Syndrome Following Ischemic Stroke: A Rare Case With a Four-Year Inter-Episode Interval.

Cureus
2025

Anti-Hu Paraneoplastic Polyradiculoneuropathy Masquerading As Guillain-Barré Syndrome: A Case Report.

Cureus
2026

A combined approach of Interleukin-8 and magnetic resonance neurography to differentiate Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.

Journal of the neurological sciences
2026

Natural experiment on neuroinflammatory disease incidence and infection links pre- and post-COVID-19.

Brain : a journal of neurology
2025

Immune Checkpoint Inhibitor-Induced Miller Fisher Syndrome: A Case of Relapsing Symptoms Requiring a Slow Corticosteroid Taper.

Cureus
2025

A case series of neuro-chikungunya: unmasking the neurotropic potential of chikungunya virus.

BMC infectious diseases
2025

Characterizing Guillain-Barré Risk Factors Among Traditional Medicare Beneficiaries.

Inquiry : a journal of medical care organization, provision and financing
2025

Neural synaptic vesicle autoimmunity following aerosolized porcine neural tissue exposure: insights into autoimmune inflammatory polyradiculoneuropathy.

EBioMedicine
2025

[Acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome)].

Arkhiv patologii
2025

An Atypical Descending Variant of Guillain-Barré Syndrome With Bulbar Palsy, Autonomic Instability, and Delayed Colonic Pseudo-Obstruction: A Case Report.

Cureus
2025

Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case-control study and cohort analysis.

The Lancet. Infectious diseases
2025

Etiologies of Acute Ataxia in Children: A Systematic Review of 1167 Subjects.

Journal of child neurology
2025

IVIg-induced false positive hepatitis B serology in a patient with Guillain-Barré syndrome: a case report.

The Pan African medical journal
2025

Guillain-Barre syndrome in patients receiving chimeric antigen receptor T-cell therapy: an individual participant data meta-analysis.

Frontiers in neurology
2025

Splenectomy Linking Guillain-Barré Syndrome, Autoimmune Haemolysis, and Epstein-Barr Virus Viraemia: Unveiling a Hidden Diagnosis of Angioimmunoblastic T-cell Lymphoma.

Cureus
Ver todos os 7.494 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Associação brasileira dedicada a Doença de Gaucher.

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Guillain-Barré

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Gelsolin-3: A Novel Myelin Autoantigen in Demyelinating Guillain-Barr&#xe9; Syndrome.
    Annals of neurology· 2026· PMID 41876953mais citado
  2. Exploring the link between adenovirus infection and Guillain-Barr&#xe9; syndrome in children: a case-based analysis.
    The Turkish journal of pediatrics· 2026· PMID 41871567mais citado
  3. Postmarketing safety surveillance for GSK's AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study.
    BMJ open· 2026· PMID 41856590mais citado
  4. A case-control neuroimaging investigation of chronic Zika virus-infected adults.
    Frontiers in human neuroscience· 2026· PMID 41798207mais citado
  5. Deciphering the Breathless Future: A Novel Approach to Predicting Respiratory Failure in Children With Guillain-Barr&#xe9; Syndrome.
    Pediatric neurology· 2026· PMID 41795250mais citado
  6. Anti-GQ1b-Positive Miller Fisher Syndrome Following Pfizer Bivalent COVID-19 Vaccination.
    Cureus· 2026· PMID 41994773recente
  7. Adaptive Therapeutic Plasma Exchange Technologies in Low-resource Settings: Utilization, Safety, and Clinical Insights from 2507 Neurological Cases.
    Ann Afr Med· 2026· PMID 41992576recente
  8. Descending Guillain-Barré Syndrome Presenting as Bilateral Phrenic Nerve Palsy.
    Ann Afr Med· 2026· PMID 41992452recente
  9. Safety of seasonal inactivated influenza vaccines in children 6 months-17 years of age in the Vaccine Adverse Events Reporting System (VAERS) 2018-2023: before, during, and after the COVID-19 pandemic public health emergency.
    Vaccine· 2026· PMID 41990612recente
  10. Effects of candidate vaccines against Zika virus infection: A systematic review of the clinical trials.
    Vaccine· 2026· PMID 41990610recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2103(Orphanet)
  2. MONDO:0016218(MONDO)
  3. Sindrome de Guillain-Barre(PCDT · Ministério da Saúde)
  4. GARD:6554(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Artigo Wikipedia(Wikipedia)
  8. Q205214(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Guillain-Barré
Compêndio · Raras BR

Síndrome Guillain-Barré

ORPHA:2103 · MONDO:0016218
🇧🇷 Brasil SUS
Geral
Prevalência
1-9 / 100 000
Herança
Multigenic/multifactorial
CID-10
G61.0 · Síndrome de Guillain-Barré
CID-11
Ensaios
13 ativos
Início
All ages
Prevalência
3.5 (Europe)
MedGen
UMLS
C0018378
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades